Leukoencephalopathy following chemotherapy for rhabdomyosarcoma: reversibility of cerebral changes demonstrated by computed tomography.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects; D003609:Dactinomycin / Q000009:adverse effects; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000175:diagnosis*; D008297:Male; D009918:Orbital Neoplasms / Q000188:drug therapy*; D012208:Rhabdomyosarcoma / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide